Ceftriaxone + Tazobactum Manufacturer Supplier in PCD Pharma Franchise
BRAND NAME FOR Ceftriaxone + Tazobactum IN PCD PHARMA FRANCHISE – AUDITROX TZ
COMPOSITION: Ceftriaxone 1000mg + Tazobactum 125mg
For rates and Schemes – Contact 8284010553
Introduction of Ceftriaxone + Tazobactum
Auditrox TZ stands as a beacon of excellence in the realm of healthcare, embodying Matins Pharma’s commitment to quality and innovation. Comprising a potent combination of Ceftriaxone 1000mg and Tazobactum 125mg, Auditrox TZ represents a formidable solution in combating bacterial infections. Developed and distributed by Matins Pharma, Auditrox TZ signifies a pinnacle in pharmaceutical advancement, catering to the needs of patients and healthcare providers alike. As a trusted supplier in PCD Pharma Franchise and Third-Party Manufacturing, Matins Pharma continues to redefine healthcare standards through Auditrox TZ.
Uses of Ceftriaxone + Tazobactum
Auditrox TZ encompasses a broad spectrum of utility, offering comprehensive coverage against various bacterial pathogens. Ceftriaxone, a third-generation cephalosporin antibiotic, exhibits potent bactericidal activity against a wide range of gram-positive and gram-negative bacteria. Tazobactum, a beta-lactamase inhibitor, enhances the efficacy of Ceftriaxone by preventing bacterial resistance mechanisms. Together, Ceftriaxone and Tazobactum synergize to combat infections such as respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and more. Auditrox TZ thus emerges as a versatile and indispensable tool in the armamentarium against bacterial diseases.
Side Effects of Ceftriaxone + Tazobactum
While Auditrox TZ boasts a commendable safety profile, it’s essential to be aware of potential side effects that may arise. Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, or abdominal pain. Allergic reactions, though rare, can manifest as rash, itching, or swelling. In some cases, severe adverse effects such as anaphylaxis or pseudomembranous colitis may occur, warranting immediate medical attention. It’s crucial to promptly report any unusual symptoms to healthcare providers for proper evaluation and management.
Safety Advice of Ceftriaxone + Tazobactum
Ensuring patient safety is paramount when utilizing Auditrox TZ in clinical practice. Healthcare professionals should exercise caution when prescribing Auditrox TZ to individuals with known allergies to cephalosporin antibiotics or beta-lactamase inhibitors. Patients with a history of renal impairment or hypersensitivity reactions to penicillin derivatives may require dose adjustments or alternative treatment options. It’s imperative to adhere strictly to the prescribed dosage regimen and duration of therapy to minimize the risk of adverse effects and prevent the development of antibiotic resistance. Regular monitoring of renal function and clinical response is essential to ensure optimal outcomes.
Dosage of Ceftriaxone + Tazobactum
The dosage of Auditrox TZ may vary depending on the type and severity of the infection, as well as the patient’s age, weight, and renal function. In general, the recommended dosage for adults is one vial of Auditrox TZ (containing Ceftriaxone 1000mg + Tazobactum 125mg) administered once or twice daily via intravenous infusion over a prescribed duration, typically ranging from 7 to 14 days. Dosage adjustments may be necessary in patients with renal impairment. Healthcare professionals should carefully assess individual patient factors and follow established guidelines for dosage determination.
The onset of therapeutic effects following Auditrox TZ administration may vary depending on the type and severity of the infection, as well as individual patient factors. In many cases, patients may experience symptomatic relief within the first few days of treatment as bacterial load decreases. However, complete eradication of the infection and resolution of symptoms may take several days to weeks, depending on the specific clinical scenario. It’s essential for patients to adhere to the prescribed treatment regimen and follow-up with healthcare providers for monitoring of clinical response and potential adjustments to therapy.
MATINS PHARMA IS A LEADING MANUFACTURER / SUPPLIER OF Ceftriaxone + Tazobactum
Matins Pharma, a leading manufacturer and supplier in the pharmaceutical industry, offers high-quality Ceftriaxone 1000mg + Tazobactum 125mg under the brand name AUDITROX TZ.
Matins Pharma is one of the fastest growing Manufacturers suppliers pan India.
WE AT MATINS PHARMA AIM FOR :
- 100% quality assurance with high efficacy and excellent results
- Improved delivery experience and shorter delivery times
- Best in class service levels through regular communication with our Supplier partners and sharing the same in a transparent manner
- Customer satisfaction and understanding the latent needs of the our business partners
- Enriching our product mix by each passing day so as to provide you everything under one roof
Why Matins Pharma is among the best PCD Pharma Franchise Company in India:
- 100 % Quality Assurance
- Direct Dealing with Company Owners
- Very High Efficacy, WHO/GMP/GLP Certified Products
- Wide Product Range
- Best in Class Packings with UV Drip Off Finish
- High Margin Products with genuine rates
- Same Day Dispatch with trusted delivery partners
- Fair and Transparent Dealing – 100 % Commitment to agreement
Address: D-1A, Ahluwalia Complex Vill. Fatehpur, Sector 20, Panchkula, 134117, Haryana
Contact Number: 82840 10553, 99155 69932, 94175 06219India
We at Matins Pharma provide wide range of quality products. We offer the following ranges in PCD Pharma Franchise:
